A newly synthesized nonsteroidal anti-inflammatory drug to treat psoriasis was presented by Dr. Jianzhong Zhang and colleagues from Peking University People's Hospital in Beijing, China.
Psoriasis is an autoimmune skin disorder that can be treated with this injectable drug.
A recent Danish study found that a 10-15 percent weight loss in obese persons with psoriasis could significantly lead to long-lasting improvement with the condition.
